Coronary stent infection: a systematic review

• Published in: Coronary artery disease Vol. 33; no. 4; p. 318
• Main Authors: Suryawan, I Gde Rurus, Luke, Kevin, Agustianto, Rafiv Fasya, Mulia, Eka Prasetya Budi
• Format: Journal Article
• Language: English
• Published: England 01.06.2022
• Subjects: Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Percutaneous Coronary Intervention - adverse effects; Stents; Treatment Outcome
• ISSN: 1473-5830
• DOI: 10.1097/MCA.0000000000001098

Coronary stent infection (CSI) is the rarest complication associated with the percutaneous coronary intervention, occurring in less than 0.1% of cases. So far, all reported instances are limited to case reports. CSI presents itself in various, often confusing, ways in clinical settings. Therefore, the current systematic review summarizes reports of CSI's clinical presentations, causative pathogens, diagnoses and treatments. This systematic review considered three online databases, using reference lists as an additional source. All case reports or case series with stent infection in the coronary artery were included - however, reviews or commentaries, articles not published in English, and articles mentioning a history of hemodialysis or any surgery were excluded. Thirty-two studies on 34 CSI patients were included in the final qualitative analysis. CSI predominantly affected males of a wide range of ages. The most common symptoms were chest pain and fever with various onsets. Interestingly, CSI usually occurred during the first stent implantation. Cultures and coronary angiography were the most common methods used to diagnose CSI. Furthermore, drug-eluting stents had a higher risk of infection than bare-metal stents. Aneurysms were the most frequent abnormalities observed in infected stents. The bacteria that most often caused CSI were Staphylococcus aureus and Pseudomonas aeroginosa. More than 90% of the reports mentioned using various antibiotics, and 74% mentioned carrying out surgery. Finally, a mortality rate of 26.47% among CSI patients was calculated.